SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-072513
Filing Date
2024-06-12
Accepted
2024-06-12 16:46:03
Documents
1
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3184
  Complete submission text file 0000950170-24-072513.txt   4725
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ALECTOR, INC. 131 OYSTER POINT BLVD. SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address
Hammond Paula (Reporting) CIK: 0001805348 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38792 | Film No.: 241038980